Please login to the form below

rheumatoid arthritis

This page shows the latest rheumatoid arthritis news and features for those working in and with pharma, biotech and healthcare.

Roche's O’Day swaps big pharma for big biotech

Selonsertib and JAK inhibitor filgotinib for rheumatoid arthritis are both potential blockbusters that are in late-stage development, according to analysts at Jefferies, and that gives O’Day a couple of

Latest news

NHS says Humira biosimilar deal will save £300m

Humira (adalimumab) is a TNF blocker used to treat inflammatory diseases such as rheumatoid arthritis, psoriasis and inflammatory bowel disease, and is currently the world’s top-selling medicine, adding more
Dupixent helps put Sanofi back on growth track

Another Regeneron-partnered drug – Kevzara (sarilumab) for rheumatoid arthritis – continues to struggle however with glacial growth since its approval in the middle of last year, adding 22m in the third quarter,
First Humira biosimilars reach EU market

diseases including rheumatoid arthritis, psoriasis and Crohn's disease.
New data keeps AbbVie’s star pipeline therapies on track

It also unveiled mid-stage data on its JAK1 inhibitor upadacitinib in atopic dermatitis, adding another clinical win to earlier successes in rheumatoid arthritis. ... AbbVie has five trials on the go in rheumatoid arthritis and will be filing in that
Gilead targets hep B in half a billion dollar deal with Precision BioSciences

The company had some good news from the field of rheumatoid arthritis earlier this week, but is still looking for a market-leading innovative drug.

More from news
Approximately 53 fully matching, plus 394 partially matching documents found.

Latest Intelligence

Finding the patient voice

rheumatoid arthritis, oncology, psychiatry, cardiovascular diseases, rare diseases etc.
The tipping point

In chronic diseases such as rheumatoid arthritis and inflammatory bowel disease, there are significantly greater savings from switching patients compared with initiating biosimilars in naïve patients alone.
Mobile health and patient outcomes

In a recent study in rheumatoid arthritis, patients saw pain as the key measure of treatment success, confounding the objective ‘clinical evidence’ of improvement.
Grünenthal's relentless pursuit of relief

Pain has nervous and inflammatory components and we are interested in everything around the inflammatory process but also the central nervous system aspect of pain and adjunctive diseases such as rheumatoid ... arthritis and Parkinson’s.
Deal Watch December 2016

510. Nuevolution (Denmark). Almirall (Spain). Research collaboration. RORγt inhibitors for inflammatory skin diseases and psoriatic arthritis. ... The Scandinavian company, Nuevolution, uses its drug discovery platform Chemetics to discover novel small

More from intelligence
Approximately 0 fully matching, plus 33 partially matching documents found.

Latest appointments

Portland Health appoints Jamie Hewitt as an account director

He joins the firm from the National Rheumatoid Arthritis Society, where he was its head of government affairs, leading the policy and public affairs functions. ... During his time at the National Rheumatoid Arthritis Society, Hewitt ran UK campaigns to
Liberation Unlimited promotes Vicky Smith

oncology, rheumatoid arthritis and eye health.
Galapagos appoints Bart Filius as chief financial officer

His vast experience in big pharma and his sharp strategic view will help us bring Galapagos to the next level, as we prepare to have our rheumatoid arthritis molecule GLPG0634 enter
TiGenix appoints Dr Marie Paule Richard

In her new role Richard will be responsible for the development of several products in Europe and the US, including rheumatoid arthritis and severe sepsis candidate Cx611 and Cx601, which is
Liberation promotes Danielle Smith to account director

Meanwhile, Vicky joined Liberation last year and in her new role will continue to work across a range of therapeutic areas including men's health, rheumatoid arthritis and eye health.

More from appointments
Approximately 1 fully matching, plus 6 partially matching documents found.

Latest from PMHub

NHS medicines optimisation milestone

for a population of patients with Rheumatoid Arthritis. To achieve this, pharma needs to consider issues such as treatment failure rates; inpatient stays, the impact on social care and a
Love Your Heart: An Innovative Interactive Video Programme

NRAS Launches 'Love Your Heart' Interactive Video Programme. A new initiative aims to decrease cardiovascular risk for people with Rheumatoid Arthritis. ... This Valentine’s Day, NRAS is delighted to announce the launch of their online, interactive
Innovation in pharma: the highs and lows of the current healthcare economy

This may cause concern to the patient and their family, but advocacy groups in relevant areas such as NRAS (National Rheumatoid Arthritis Society) and Crohns and Colitis UK both provide extensive
THE OTHER SIDE OF … RHEUMATOID ARTHRITIS

At age 26, Georgie was diagnosed with rheumatoid arthritis, an autoimmune inflammatory condition that affects up to 1% of the population worldwide. ... joints. So what contributed to this? On the one hand, time-lags between initial symptoms and diagnosis
How Can We Make Payer Communications Really Sing?

We carried out research with 20 local level decision-makers involved in access decisions for diabetes and rheumatoid arthritis.We had two main goals:.

More from PMHub
Approximately 6 fully matching, plus 16 partially matching documents found.

Featured jobs

Editorial Assistant Medical Education Agency: £25, 000 - £26, 000

Home-based Senior Project Manager – Independent Med Ed: Salary TBC

Senior Medical Writer: Salary TBC

Account Director, Medical Education: Salary TBC

Global Business Development Director – Health Education: excellent commission

Account Director – Health Policy – Global Agency: Salary TBC

Account Manager / Account Director: Competative

Client Services Director – Medical Education Agency – North West...: Salary TBC

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Account Director – Healthcare Marketing – Berks: Salary TBC

Medical Writer: Salary TBC

Senior Account Manager, Rare Diseases – Medical Communications, ...: Excellent package

Account Manager / Senior Account Manager: 35, 000-40, 000

Account Director, Healthcare Marketing Agency: Salary TBC

Senior Account Director development role to Business Director, H...: Excellent package

Engagement Expert, Healthcare Brand Communications, London: Excellent package

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Associate Director: £75, 000-90, 000

Subscribe to our email news alerts

PMHub

Add my company

Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...